Difficulty: Medium
Average Score: 81%
Practice
Which of the following would not be included as a symptom of drug-induced parkinsonism?
Correct answer
D
Rationale
In the context of drug-induced parkinsonism, the correct answer is D) Tachycardia, as it is not a common symptom associated with this condition. Drug-induced parkinsonism is characterized by symptoms that mimic Parkinson's disease due to the use of certain medications, such as antipsychotics.
A) Stooped posture is a common symptom in drug-induced parkinsonism, as it reflects the postural changes seen in Parkinson's disease.
B) Cogwheel rigidity is another common symptom, referring to the jerky resistance to passive movement typical of parkinsonian rigidity.
C) Drooling is also commonly seen in drug-induced parkinsonism due to the changes in facial muscles and swallowing difficulties.
Understanding the differentiation of symptoms in drug-induced parkinsonism is crucial for healthcare professionals to provide accurate diagnoses and appropriate treatment plans. Recognizing these distinctions can prevent misdiagnosis and ensure proper management of patients experiencing these symptoms. This information is vital in the field of public health as it enhances the quality of care provided to individuals with drug-induced parkinsonism, ultimately contributing to improved health outcomes and patient well-being.
A) Stooped posture is a common symptom in drug-induced parkinsonism, as it reflects the postural changes seen in Parkinson's disease.
B) Cogwheel rigidity is another common symptom, referring to the jerky resistance to passive movement typical of parkinsonian rigidity.
C) Drooling is also commonly seen in drug-induced parkinsonism due to the changes in facial muscles and swallowing difficulties.
Understanding the differentiation of symptoms in drug-induced parkinsonism is crucial for healthcare professionals to provide accurate diagnoses and appropriate treatment plans. Recognizing these distinctions can prevent misdiagnosis and ensure proper management of patients experiencing these symptoms. This information is vital in the field of public health as it enhances the quality of care provided to individuals with drug-induced parkinsonism, ultimately contributing to improved health outcomes and patient well-being.